Fixed-dose combination of rosuvastatin and ezetimibe: treating hypercholesteremia according to cardiovascular risk
Introduction: Reducing low-density lipoprotein cholesterol (LDL-C) with lipid-lowering
therapies has been associated with a decrease in the frequency of cardiovascular events …
therapies has been associated with a decrease in the frequency of cardiovascular events …
Rosuvastatin and ezetimibe for the treatment of dyslipidemia and hypercholesterolemia
C Boutari, A Karagiannis, VG Athyros - Expert review of …, 2021 - Taylor & Francis
Introduction: Statins are powerful lipid-lowering agents which reduce cardiovascular (CV)–
related morbidity and mortality. However, a large proportion of patients cannot attain the …
related morbidity and mortality. However, a large proportion of patients cannot attain the …
Efficacy and safety of ezetimibe and rosuvastatin combination therapy versus those of rosuvastatin monotherapy in patients with primary hypercholesterolemia
Purpose The aim of this study was to evaluate the safety and efficacy of combination
treatment of rosuvastatin with ezetimibe in patients with primary hypercholesterolemia …
treatment of rosuvastatin with ezetimibe in patients with primary hypercholesterolemia …
Combination therapy of rosuvastatin and ezetimibe in patients with high cardiovascular risk
YJ Yang, SH Lee, BS Kim, YK Cho, HJ Cho… - Clinical …, 2017 - Elsevier
Purpose The aim of this study was to evaluate the efficacy and tolerability of
rosuvastatin/ezetimibe combination therapy in Korean patients with high cardiovascular risk …
rosuvastatin/ezetimibe combination therapy in Korean patients with high cardiovascular risk …
Combination therapy of ezetimibe and rosuvastatin for dyslipidemia: current insights
MR Chilbert, D VanDuyn, S Salah… - Drug design …, 2022 - Taylor & Francis
Cardiovascular disease is one of the leading causes of death around the world with various
efforts being made to reduce risk in patients through preventive measures. One major …
efforts being made to reduce risk in patients through preventive measures. One major …
Rosuvastatin/ezetimibe: a review in hypercholesterolemia
YN Lamb - American journal of cardiovascular drugs, 2020 - Springer
Rosuvastatin/ezetimibe combines two lipid-lowering agents: rosuvastatin, an HMG-CoA
reductase inhibitor (ie statin) with particularly strong inhibitory effects on hepatic cholesterol …
reductase inhibitor (ie statin) with particularly strong inhibitory effects on hepatic cholesterol …
Effect of fixed‐dose combinations of ezetimibe plus rosuvastatin in patients with primary hypercholesterolemia: MRS‐ROZE (Multicenter Randomized Study of …
KJ Kim, SH Kim, YW Yoon, SW Rha… - Cardiovascular …, 2016 - Wiley Online Library
Aim We aimed to compare the effects of fixed‐dose combinations of ezetimibe plus
rosuvastatin to rosuvastatin alone in patients with primary hypercholesterolemia, including a …
rosuvastatin to rosuvastatin alone in patients with primary hypercholesterolemia, including a …
Ezetimibe and rosuvastatin combination treatment can reduce the dose of rosuvastatin without compromising its lipid-lowering efficacy
Purpose The goal of this study was to compare the lipid-lowering efficacy of the combination
of ezetimibe and low-or intermediate-intensity statin therapy versus that of high-intensity …
of ezetimibe and low-or intermediate-intensity statin therapy versus that of high-intensity …
[HTML][HTML] A phase III, multicenter, randomized, double-blind, active comparator clinical trial to compare the efficacy and safety of combination therapy with ezetimibe and …
SJ Hong, HS Jeong, JC Ahn, DH Cha, KH Won… - Clinical …, 2018 - Elsevier
Purpose Combination therapy with ezetimibe and statins is recommended in cases of statin
intolerance or insufficiency. The objective of this study was to compare the efficacy and …
intolerance or insufficiency. The objective of this study was to compare the efficacy and …
[HTML][HTML] Effects of fixed-dose combination of low-intensity rosuvastatin and ezetimibe versus moderate-intensity rosuvastatin monotherapy on lipid profiles in patients …
SA Lee, W Kim, TJ Hong, Y Ahn, MH Kim, SJ Hong… - Clinical Therapeutics, 2021 - Elsevier
Purpose We investigated whether the combination therapy of low-intensity rosuvastatin and
ezetimibe is an useful alternative to moderate-intensity rosuvastatin monotherapy in patients …
ezetimibe is an useful alternative to moderate-intensity rosuvastatin monotherapy in patients …